TradingView
warrenhochfeld
3 sty 2018 12:25

Achaogen Rebound Likely In 2018-Long Long

NASDAQ:AKAO180

Opis

⋅
Expected rebound ahead of the 25 June FDA action date for Plazomicin for the Treatment of Complicated Urinary Tract Infections and Bloodstream Infections
Trend AnalysisBeyond Technical Analysis
Więcej